COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies

BACKGROUND AND AIM: In December 2019, the first cases of SARS-CoV-2 infection were detected in Wuhan. Within two months, it had begun to spread around the world in what became an unprecedented pandemic. Patients with Multiple Sclerosis (MS) in a state of immunosuppression may be considered at risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Meca-Lallana, Virginia, Aguirre, Clara, Beatrizdel Río, Cardeñoso, Laura, Alarcon, Teresa, Vivancos, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295509/
https://www.ncbi.nlm.nih.gov/pubmed/32585617
http://dx.doi.org/10.1016/j.msard.2020.102306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295509/
https://www.ncbi.nlm.nih.gov/pubmed/32585617
http://dx.doi.org/10.1016/j.msard.2020.102306

Ejemplares similares